TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 73 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2014. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $2,943,000 | +31.0% | 293,500 | -2.5% | 1.16% | +29.7% |
| Q3 2015 | $2,246,000 | -84.0% | 301,100 | +2.5% | 0.90% | -81.2% |
| Q2 2015 | $14,061,000 | +20.7% | 293,675 | -7.6% | 4.76% | +11.1% |
| Q1 2015 | $11,647,000 | -4.1% | 317,900 | +4.0% | 4.28% | -8.0% |
| Q4 2014 | $12,141,000 | +71.8% | 305,750 | -13.7% | 4.65% | +67.9% |
| Q3 2014 | $7,068,000 | +48.9% | 354,300 | +0.7% | 2.77% | +63.2% |
| Q2 2014 | $4,748,000 | +31.5% | 352,000 | +6.2% | 1.70% | +18.0% |
| Q1 2014 | $3,611,000 | -6.4% | 331,600 | +16.1% | 1.44% | -9.7% |
| Q4 2013 | $3,859,000 | +125.8% | 285,500 | +90.1% | 1.59% | +83.6% |
| Q3 2013 | $1,709,000 | – | 150,200 | – | 0.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 664,000 | $2,543,000 | 0.82% |
| GREAT POINT PARTNERS LLC | 452,375 | $1,733,000 | 0.44% |
| Clearline Capital LP | 267,915 | $1,026,000 | 0.32% |
| Rhenman & Partners Asset Management AB | 300,000 | $1,149,000,000 | 0.18% |
| Rock Springs Capital Management LP | 662,500 | $2,537,000 | 0.16% |
| Eventide Asset Management | 600,000 | $2,298,000 | 0.14% |
| Granahan Investment Management | 657,496 | $2,518,000 | 0.08% |
| Candriam S.C.A. | 374,000 | $1,432,000 | 0.03% |
| Tekla Capital Management LLC | 192,322 | $737,000 | 0.03% |
| DOW CHEMICAL CO /DE/ | 65,000 | $249,000 | 0.02% |